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RNA editing by members of the ADAR (adenosine
deaminase that acts on RNA) enzyme family involves
hydrolytic deamination of adenosine to inosine within
the context of a double-stranded pre-mRNA substrate.
Editing of the human GluR-B transcript is catalyzed by
the enzyme ADAR2 at the Q/R and R/G sites. We have
established a minimal RNA substrate for editing based
on the R/G site and have characterized the interaction of
ADAR2 with this RNA by gel shift, kinetic, and cross-
linking analyses. Gel shift analysis revealed that two
complexes are formed on the RNA as protein concentra-
tion is increased; the ADAR monomers can be cross-
linked to one another in an RNA-dependent fashion. We
performed a detailed kinetic study of the editing reac-
tion; the data from this study are consistent with a re-
action scheme in which formation of an ADAR2RNA
ternary complex is required for efficient RNA editing
and in which formation of this complex is rate determin-
ing. These observations suggest that RNA adenosine
deaminases function as homodimers on their RNA sub-
strates and may partially explain regulation of RNA ed-
iting in these systems.
Eukaryotic precursor-mRNAs (pre-mRNAs) are subject to a
variety of post-transcriptional modifications that regulate gene
expression. These modifications, collectively referred to as
RNA processing reactions, include 5- and 3-end formation,
RNA splicing, polyadenylation, and the recently characterized
phenomenon of RNA editing (reviewed in Refs. 1–3). RNA
editing involves changes in the information content of the pri-
mary transcript by the specific insertion, deletion, or chemical
modification of nucleotides. This latter class of editing reac-
tions includes the hydrolytic deamination of adenosine (A) to
inosine (I) within the context of double-stranded RNA. Deami-
nation events of this type have been demonstrated in both viral
and cellular transcripts. For example, the life-cycle of the Hep-
atitis  virus is regulated by an editing event in the anti-
genome in which a UAG stop codon is converted to a UIG
tryptophan codon (4). As well, A to I editing is involved in the
regulation of function of a growing number of cellular factors.
Tissue-specific editing of the serotonin 5-HT2C receptor results
in a 10–15-fold reduction in response to serotonin agonists and
thus may be involved in the regulation of cellular response to
neurotransmitters (5). Recently, A to I editing has been shown
to be essential for erythropoeisis in mice (6). Transcripts for
subunits of the neural-specific AMPA class of glutamate-gated
(GluR) ion channels undergo A to I modification at two posi-
tions, the Q/R and R/G (see Fig. 1A) editing sites, which affect
the properties of the resulting channels (7–11).
Relatively little is known about the determinants for specific
A to I deamination in pre-mRNA substrates. In the case of
GluR-B pre-mRNAs, it has been demonstrated that editing at
both the Q/R and R/G sites requires a double-stranded struc-
ture formed between sequences proximal to the editing site and
downstream intron sequences (8, 9, 12, 13). Mutation of the
intron sequence to abolish the double-stranded sequence at the
Q/R site prevents editing and is an embryonic lethal event in
mice (14). The disposition of the edited nucleotide during the
editing event is unclear; in the native Q/R substrate the target
adenosine is contained within a perfect duplex, which is not the
case with the R/G substrate (see Fig. 1A). It is also unclear
whether there are specific sequences that direct the site of RNA
editing or whether the targeting is dictated by a specific spatial
arrangement of double-stranded RNA.
The first RNA deaminase to be cloned, ADAR11 (adenosine
deaminase that acts on RNA) (15–18) was identified originally
as an activity responsible for unwinding double-stranded RNA
(19–21). Subsequently, this unwinding activity was correlated
with deamination of A to I within double-stranded RNA sub-
strates (22). ADAR1 exhibited low deaminase activity with a
number of specific substrates, including the Q/R site of the
GluR-B pre-mRNA, but has been shown to efficiently edit the
R/G site of GluR-B as well as the anti-genome of Hepatitis 
virus (4, 23–25). Screening of a rat hippocampal cDNA library
with probes complementary to the deaminase domain of
ADAR1 resulted in the cloning of ADAR2 deaminase (26).
ADAR2a, the shorter of two human isoforms, is an 80-kDa
protein containing two N-terminal double-stranded RNA bind-
ing domains as well as a C-terminal deaminase domain (27).
ADAR2 has been shown to efficiently edit both the Q/R and
R/G sites of the GluR-B transcript, and in contrast to ADAR1 it
does not exhibit activity at a position within intron 11 of
GluR-B (see Fig. 1A) (23, 26). These facts, together with the
biochemical purification of ADAR2 along with the Q/R deami-
nase activity (28) strongly support the identification of ADAR2
as the cellular factor responsible for editing of the GluR-B
transcript. The mechanism of action of ADAR2 on its RNA
substrates is unclear. Little is known about the mechanism of
RNA binding or substrate activation for the deamination event.
To study the molecular basis for RNA recognition and adeno-
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sine deamination by members of the ADAR family, we have
undertaken a series of studies involving hADAR2a using the
R/G site of the human GluR-B pre-mRNA as a model system.
We have characterized this minimal system using kinetic, gel
shift, and cross-linking analyses. Interestingly, we have found
that a ternary complex involving the association of two ADAR2
monomers with the RNA substrate is responsible for editing
activity. Furthermore, the monomers can be cross-linked to one
another in an RNA-dependent fashion, suggesting intimate
association on the substrate. An analysis of RNA binding and
R/G site editing using two deletion mutants indicates that
association of ADAR2 with the editing site in a 1:1 complex is
insufficient to yield efficient A to I editing. These results com-
bined with previous observations suggest that editing of
pre-mRNAs by members of the ADAR class of enzymes is
contingent on homo- or hetero-dimerization on the RNA sub-
strate and that this requirement is central to the regulation of
editing by these enzymes.
EXPERIMENTAL PROCEDURES
Enzyme Overexpression and Purification—hADAR2a, with an N-
terminal FLAG epitope and C-terminal His6 tag, was expressed and
purified from a recombinant Pichia pastoris clone (a generous gift of W.
Keller, University of Basel) as described previously (27). Following
chromatography on a Macro-Prep High Q column (Bio-Rad), fractions
containing ADAR2, as identified by Western analysis with anti-FLAG
antibody (Sigma), were pooled, mixed for 30 min with 2 ml of Ni2
agarose (Qiagen) that had been pre-equilibrated with buffer C (200 mM
KCl, 10% glycerol, 50 mM Tris (pH 7.9), 5 mM -mercaptoethanol, 0.01%
Nonidet P-40, 0.5 mM phenylmethylsulfonyl fluoride, 0.7 g/ml pepsta-
tin, 0.4 g/ml leupeptin), and poured into a 5-ml column. The column
was washed with 10 ml of buffer C containing 20 mM imidazole, and the
protein was eluted with buffer C containing 250 mM imidazole.
The fractions from the nickel nitrilotriacetic acid column containing
ADAR2 were dialyzed against buffer E (10 mM Hepes pH 8, 100 mM
KCl, 1 M NaCl, 0.5 M (NH4)2SO4, 0.5 M DTT) and loaded onto a 1-ml
Hi-Trap Phenyl column (Amersham Biosciences). The phenyl column
was washed with 10-column volumes of buffer E and eluted with a
15-ml gradient from buffer E to buffer F (10 mM Hepes pH 8, 100 mM
KCl, 0.5 mM DTT). The fractions containing ADAR2 were dialyzed into
editing buffer (20 mM Hepes pH 8, 100 mM KCl, 0.5 mM DTT, 0.01%
Nonidet P-40, 20% glycerol) and stored at 80 °C. Protein was quanti-
fied by comparing Sypro-Red (Molecular Dynamics) intensity to known
amounts of bovine serum albumin using SDS-PAGE.
Preparation of RNA—R/G editing substrates of various lengths were
synthesized by T7 RNA polymerase transcription using templates gen-
erated by PCR from a substrate cloned into pBS (Stratagene). Mobility
shift and editing assays were performed using R/G substrates inter-
nally labeled with a single 32P label 5 to the edited adenosine. The
internal label was introduced by the ligation of upstream and 32P-end-
labeled, ApG-primed, downstream T7 transcription products in the
presence of a bridging oligonucleotide using T4 DNA ligase (300 pmol of
5-RNA, 100 pmol of 3-RNA, 100-pmol DNA bridge) (29). All RNAs
were purified by denaturing PAGE (15%, 19:1) before use and stored in
double distilled water at 80 °C.
Editing Reactions—Editing reactions containing 20 mM Hepes pH
8.0, 100 mM KCl, 0.5 mM DTT, 20% glycerol, 0.01% Nonidet P-40,
RNasin (1 unit/l, Roche Molecular Biochemicals) and varying amounts
of ADAR2 were initiated by the addition of substrate RNA. A fixed RNA
concentration of 0.5 nM was used for the protein titration experiments,
and a fixed concentration of 50 nM ADAR2 was used in the RNA
titration experiments. The substrate RNA was denatured at 80 °C for 2
min and allowed to renature at 30 °C for 10 min just prior to addition to
the editing reactions. At each time point, an aliquot was removed and
quenched by its addition to stop solution (6% SDS, 250 mM Tris, pH 8.0,
25 mM EDTA) at 80 °C. Each sample was diluted to 200 l, made 0.3 M
in NaOAc, and extracted once with phenol/chloroform/isoamyl alcohol
and once with chloroform, and ethanol was precipitated. The pellet was
resuspended in 10 l of double distilled water and digested with Nu-
clease P1 (0.5 units/reaction; Amersham Biosciences), and the products
were resolved by thin layer chromatography (saturated (NH4)2SO4:0.1
M NaOAc:isopropanol; 79:19:2, v/v) (10) using cellulose-polyethylenei-
mine chromatography plates (J. T. Baker). The TLC plates were ex-
posed to a Molecular Dynamics Phosphor screen which was scanned
using a Molecular Dynamics Storm 860 PhosphorImager. The extent of
editing was quantified using ImageQuant 5.0 software. Data from three
separate experiments were averaged, and the extent of editing versus
time was plotted; initial rates were determined by calculating the slope
of the best fit through the first few time points. Two separate calcula-
tions of the rate constant for ESE formation (using data from experi-
ments in which either substrate or enzyme concentration was varied)
were performed using Dynafit (BioKin Ltd.).
Gel Mobility Shift Assays—Reactions were prepared as described
above for editing assays and incubated for 10 min at 30 °C before being
resolved by native 5% (89:1) PAGE. The gels were run at room temper-
ature in TBE buffer (0.089 M Tris-base, 0.089 M boric acid, 0.2 mM
EDTA) for 1.5 h at 150 volts. Gels were dried and exposed to a Molec-
ular Dynamics Phosphor screen that was scanned on a Molecular Dy-
namics Storm 860 PhosphorImager. Data were analyzed using Total-
Lab V1.11 software (Phoretix).
Dissociation constants were determined from data obtained in at
least three separate experiments by quantifying the fractions of free
RNA (), RNA bound in the ES complex 1 (1), and RNA bound in the
ESE complex 2 (2), and simultaneously fitting equations 2, 3, and 4
(Microsoft EXCEL). Because the gel shift analysis does not differentiate
between substrate and product and the reaction proceeds quickly, it is
assumed that ES is equivalent to EP and that ESE is equivalent to EPE
in the equations below. Because ADAR2 is in large excess of the RNA
substrate, E is approximately equal to the total amount of enzyme
added to each reaction.
E SL|;
Kd1
ES ES SL|;
Kd2
ESE (Eq. 1)
 
Kd1Kd2[S]T
Kd1Kd2 Kd2[E] [E]2
(Eq. 2)
1 
Kd2[S]T
[E]Kd2 Kd1Kd2/[E]
(Eq. 3)
2 
[S]T
1Kd2/[E]Kd1Kd2/[E]2
(Eq. 4)
Protein-Protein Cross-linking—Binding reactions (10 l) containing
300 nM ADAR2, 20 mM Hepes pH 8.0, 100 mM KCl, and varying
amounts of R/G RNA were set up on ice. The reactions were allowed to
equilibrate for 15 min before cross-linking was initiated by the addition
2 l of 45 mM dimethyl suberimidate hydrochloride (DMS; Pierce). After
4 h at room temperature the reactions were quenched by the addition of
2 l of 1 M glycine. Samples were separated by SDS-PAGE (8%; 29:1).
The gel was then transferred to polyvinylidene fluoride membrane
(Bio-Rad). Western blotting was performed using anti-FLAG antibody,
and products were visualized using the phototope-horseradish peroxi-
dase detection kit (Cell Signaling Technology).
RESULTS
Adenosine to Inosine Editing in Model R/G RNAs—Recombi-
nant ADAR2 was expressed and purified to homogeneity from
a P. pastoris expression system yielding 100 g of protein per
liter of culture. Using this protein we were able to demonstrate
high levels of A to I conversion, using an inosine-specific cleav-
age assay (29), in a 500-nucleotide RNA containing the Q/R
editing site of the human GluR-B pre-mRNA and a 78-nucleo-
tide RNA containing the R/G editing site of the same
pre-mRNA (data not shown). We focused further studies of
ADAR2 mediated editing on RNAs based on the R/G site be-
cause it is smaller and simpler in structure. The strength of
ADAR2-RNA interactions was measured by gel mobility shift
and the efficiency of A to I conversion was measured using a
nuclease/TLC assay (Fig. 1B) with RNA internally labeled ad-
jacent to the target adenosine (29, 30).
Gel Mobility Analysis of ADAR2-RNA Interaction—It has
been shown previously that ADAR2 can form two complexes on
an RNA substrate (31), but it has been unclear which of these
was associated with catalysis of editing. In our studies of
ADAR2 using the 78-nucleotide R/G substrate, we also ob-
served the formation of two complexes. We performed gel mo-
bility shift experiments and editing reactions under identical
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conditions to investigate which complex was responsible for
ADAR2 activity. Using a native gel analysis, all of the RNA
probe could be shifted into an RNA-protein complex (ES; Fig.
2A) at low concentrations of protein and this in turn could be
shifted into a higher order complex (ESE; Fig. 2A). The equi-
librium dissociation constants for these two complexes were
determined to be 4 and 21 nM, respectively. The total amount of
editing observed with low and high concentrations of ADAR2
was similar over long time courses (24 h; 85%). This result
suggests that formation of the ESE complex does not inhibit
R/G site editing. To investigate the mechanism of editing more
closely, we carried out a detailed kinetic analysis of the
reaction.
Kinetics of R/G Site Editing—We performed a kinetic anal-
ysis of the R/G editing event by determining initial rates of
editing under conditions in which either substrate or ADAR2
concentration was varied. Intriguingly, we were unable to ob-
serve substrate saturation of the editing reaction. Under con-
ditions in which the concentration of ADAR2 was held constant
and substrate concentration was increased, the initial rate
increased until the substrate concentration was roughly half of
the protein concentration, and then it decreased (Fig. 3A). This
observed inhibition is consistent with a mechanistic scheme in
which formation of the ES complex is not sufficient for editing.
Instead, efficient editing requires formation of the ESE com-
plex; excess substrate sequesters ADAR2 in the inactive ES
complex. If the ES complex was competent for editing, one
would expect saturation at increased substrate concentrations
(if the conversion of ES to EP was rate-limiting) or a linear
dependence of rate on substrate concentration (if formation of
ES was rate-limiting); neither was observed, consistent with
the formation of ESE being required for editing.
In order to investigate the editing reaction further, we held
the RNA concentration constant and varied the concentration
of ADAR2. The initial rate increased over the entire range of
enzyme concentrations tested, and a plot of initial rate versus
enzyme concentration was linear (Fig. 3B). This suggests that the
concentration of ESE in the reaction does not reach equilibrium
before it is converted to product and that the rate-determining
step of editing involves enzyme association with the ES complex.
RNA-dependent Cross-linking of ADAR2—We investigated
the nature of the higher order RNA-ADAR2 complex by per-
forming cross-linking experiments with the bifunctional
amine-reactive reagent DMS. ADAR2 was incubated with var-
ious concentrations of R/G site RNA followed by cross-linking
with DMS and analysis by SDS-PAGE and Western blotting.
These experiments showed the formation of an RNA-dependent
protein-protein cross-link with a molecular weight consistent
with that of an ADAR2 dimer (Fig. 4). The cross-link was not
sensitive to nuclease P1 treatment after cross-linking, indicat-
ing that it represents a protein-protein interaction (data not
shown). The efficiency of cross-linking was dependent on RNA
concentration (Fig. 4, lanes 4–6); the observed cross-link di-
minished at the highest RNA concentrations tested consistent
with ADAR2 being sequestered in the 1:1 ES complex.
Substrate Deletion Analysis—RNA substrates with specific
deletions were synthesized to determine which parts of the
78-nucleotide substrate were necessary for both binding and
editing by ADAR2. A 58-nucleotide RNA substrate was synthe-
sized that had a region distal to the hairpin loop removed and
placed the target adenosine at the 5-end of the substrate, and
a 54-nucleotide RNA substrate was synthesized that had a
region proximal to the hairpin loop removed (Fig. 5). Binding
studies (Fig. 5A) revealed that the 58-nucleotide RNA could
form two complexes with ADAR2, although the affinity of the
protein for this RNA was 7-fold less than that observed for
the formation of complexes with the 78-nucleotide RNA. Only
one complex was formed upon incubation of ADAR2 with the
54-nucleotide RNA; the dissociation constant for formation of this
complex was18-fold greater than that observed for formation of
the analogous complex on the 78-nucleotide substrate. Initial
editing rates of both the 58- and 54-nucleotide RNAs, determined
using ADAR2 concentrations that shifted 50% of the RNAs into
the ES complex, were 100-fold slower than those observed
using the 78-nucleotide RNA (Fig. 5B). These results suggest
that portions of both deleted regions are important for binding of
the R/G site by ADAR2 and confirm that formation of the ES
complex involves RNA binding in the immediate vicinity of the
editing site; furthermore, a substrate severely compromised in its
ability to form the ESE complex is edited inefficiently.
FIG. 1. Editing at the R/G site of GluR-B pre-mRNA. Panel A, ADAR2 catalyzes the conversion of adenosine (A) to inosine (I) within
pre-mRNA substrates (top). RNA editing at the R/G site of the GluR-B pre-mRNA takes place within the context of a double-stranded RNA formed
between nucleotides immediately proximal to the editing site and nucleotides downstream of intron 13 (bottom). The deamination of the indicated
adenosine to inosine results in an arginine to glycine codon change in the mature mRNA (inset). Panel B, nuclease/TLC assay for editing at the
R/G site catalyzed by recombinant ADAR2 using a 78-nucleotide RNA containing the R/G site internally labeled with 32P 5 to the editing site: lane
1, unedited RNA; lane 2, RNA in the presence of ADAR2.
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DISCUSSION
We have carried out a detailed kinetic study of RNA editing
by a member of the ADAR enzyme class using an RNA that
closely resembles the R/G editing site in the GluR-B
pre-mRNA. Substrate inhibition of editing, as determined by
measurement of initial rates, is consistent with a kinetic model
(Scheme A) in which the formation of a ternary enzyme-sub-
strate complex (ESE) is required for efficient editing. As sub-
strate concentration increases, free enzyme is sequestered in
the ES complex and is unavailable to form the active ESE
complex. Under this scheme,
E SL|;
KS
ESO¡
k1
E
ESEO¡
fast
EPE
SCHEME A
V0 
k1[E]2[S]T
KS  [E]
(Eq. 5)
the linear dependence of initial rate on enzyme concentration
suggests that ES rapidly reaches equilibrium and that forma-
tion of the ESE complex is rate-limiting. When the concentra-
tion of enzyme is much higher than substrate, the initial rate
(Vo) is given by Equation 5; the linear dependence of initial rate
on total enzyme concentration is clear under conditions where
[E] is much greater than Ks. Finally, we found a strong corre-
lation between our kinetic analysis and Scheme A; we calcu-
lated the rate constant (k1) for formation of ESE under condi-
tions of excess substrate or excess enzyme and obtained very
similar values of 0.20 0.04 pM1s1 and 0.21 0.01 pM1s1,
respectively.
It is possible that the association of a second ADAR2 protein
with the RNA is independent of the first binding event and that
the second event represents binding of the target adenosine to
the enzyme active site with no participation of the other mon-
omer. Several pieces of evidence argue against these sugges-
tions. First, chemical and enzymatic footprinting of both
ADAR2 complexes have shown that the first binding event
corresponds to protection of the editing site with an extended
footprint observed at higher protein concentrations (31). Sec-
ond, we deleted distal regions of the R/G substrate, preserving
the sequence proximal to the editing site, and observed a dra-
matic reduction in editing efficiency. Thus, initial binding of
ADAR2 corresponds to protein-RNA association in the vicinity
of the editing site, but the editing reaction itself requires asso-
ciation of a second ADAR2 monomer with the RNA substrate. It
is unclear whether the chemistry of deamination is associated
with the active site of the first or second monomer.
Gel filtration and glycerol gradient sedimentation experi-
ments performed with another member of the ADAR family of
enzymes, ADAR1, indicated that ADAR1 exists as a monomer
in solution (32). Hough and Bass (33) reported that partially
purified Xenopus ADAR1 formed complexes of 215 kDa
FIG. 2. Native mobility shift analysis. A, native mobility shift
PAGE analysis of ADAR2 interaction with the 78-nucleotide R/G RNA
showing the formation of two complexes under editing conditions. Re-
actions were incubated for 10 min at 30 °C and loaded directly onto 5%
native gels (89:1). ADAR2 concentrations in lanes 1–8 are 0, 1, 5, 10, 25,
50, 100, and 150 nM. The RNA concentration was kept constant at 0.5 nM.
B, graphical representation of the native mobility shift PAGE analysis.
Plot shows the fraction of species at differing ADAR2 concentrations
(filled circles, S; filled boxes, ES; filled triangles, ESE). Dissociation con-
stants were determined as described under “Experimental Procedures.”
Data points are the average of three independent experiments with the
uncertainty represented by 1 S.D. The indicated fit is to a binding scheme
in which ESE formation is contingent on initial binding of ADAR2 to the
RNA to form ES (see “Experimental Procedures”).
FIG. 3. Kinetics of ADAR2 RNA editing. A, initial rate of editing as a function of substrate concentration. Increasing amounts of an internally
labeled 78-nucleotide R/G RNA were added to editing reactions containing 50 nM ADAR2, and the amount of product formed at various times was
determined. Initial rates were calculated by measuring the slope through the first few points of the plot of product versus time (data not shown).
The inset represents an expansion of the initial portion of the substrate titration. B, initial rate of editing as a function of substrate concentration.
Initial rates were determined by calculating the slope through the first few points of the plot of product versus time.
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(consistent with dimer formation) but behaved as monomers
when fully purified. The presence of RNA in the partially
purified protein preparation would explain these results.
Cross-linking experiments with the bifunctional reagent
DMS show that there is an intimate association between
ADAR2 monomers on the R/G RNA and also that this asso-
ciation is RNA-dependent (Fig. 4).
Comparison of the ADAR class of enzymes with related en-
zymes suggests that dimerization may be conserved as a func-
tional requirement. Relatively little is known regarding the
catalysis of A to I deamination within the context of double-
stranded RNA, but it has been assumed that the chemical
mechanism is related to that of the adenosine and cytidine
nucleotide deaminases (34). In both classes of enzymes an
active site zinc, coordinated by cysteine or histidine residues,
serves to activate water for attack on the purine or pyrimidine
base. Sequence comparisons show relatively little homology
between the ADAR family active sites and those of other deami-
nases with the exception of the presence, identity, and relative
arrangement of the putative zinc coordinating signature resi-
dues; mutagenesis of these residues in ADAR1 supports their
roles in catalysis. Interestingly, the identity and arrangement
of the signature residues in the ADAR family is more reminis-
cent of the cytidine deaminases than of the adenosine deami-
nases. In the cytidine deaminases, zinc is coordinated by His,
Cys, and Cys whereas coordination in the adenosine deami-
nases involves three Cys residues. Additionally, both the cyti-
dine deaminases and ADAR enzymes contain the His-Ala-Glu
triad; the acid residue likely acts as a proton donor and accep-
tor during the course of catalysis. The adenosine deaminases
function as monomers, but many cytidine deaminases includ-
ing Escherichia coli cytidine deaminase (35), the T4 bacteri-
ophage cytidine deaminase (36), and the apoB mRNA editing
deaminase (37) function as dimeric or polymeric species. The
x-ray structure of the E. coli cytidine deaminase dimer shows
that the active site is partially formed by contributions from
each monomer (35).
Recently, a class of tRNA-specific adenosine deaminases has
been characterized by Gerber and Keller (38, 39). Members of
the ADAT (adenosine deaminases that act on tRNA) enzyme
family share sequence homology in editing domains with both
the cytidine deaminases and members of the ADAR family; it
has been suggested that ADAT enzymes evolved into the ADAR
class by the acquisition of double-stranded RNA binding do-
mains. The fact that tad2p (ADAT2) and tad3p (ADAT3) form
heterodimers supports the observation that ADAR2 functions
as a dimeric species.
The enzymatic activity of the RNA-dependent protein kinase
PKR has been shown to depend on dimer formation, although
the mechanism of dimerization is the subject of controversy
(40). The sequence of PKR includes two N-terminal double-
stranded RNA binding domains and a C-terminal catalytic
domain and is thus reminiscent of the domain structure of
ADAR2. Future experiments with ADAR2 will involve the lo-
calization of the dimerization interface within the protein
sequence.
Dimerization of ADAR2 on RNA may influence the editing
activity of the enzyme in several ways. For example, the bind-
ing of a second ADAR2 monomer on its substrate may effect a
conformational change in one or both monomers that is re-
quired for editing. Results from tryptophan quenching experi-
ments are consistent with ADAR2 undergoing a conformational
change upon the binding of RNA (41). An additional piece of
evidence supporting the need for a conformational change in
ADAR2 before editing is the observation that a potent inhibitor
of adenosine deaminase, coformycin (Kd 10
15 M), does not
inhibit the activity of members of the ADAR family (15). Re-
cently, Nishikura and coworkers (42) have demonstrated that
the mixing of ADAR3 with either ADAR1 or ADAR2 attenuated
the editing activity of the latter two enzymes, whereas mixing
ADAR1 and ADAR2 lowered the site selectivity of the A to I
editing activity; in light of the data reported here, we interpret
these observations to indicate that members of the ADAR fam-
ily can form hetero- as well as homodimers on RNA substrates.
The requirement of ADAR dimerization for editing as well as
FIG. 4. RNA-dependent cross-linking of ADAR2. The enzyme
(300 nM) was mixed with varying amounts of unlabeled R/G RNA and
incubated with the protein-protein cross-linker DMS. Samples were run
on SDS-PAGE and analyzed by Western blotting with anti-FLAG an-
tibody. RNA concentrations (nM) for lanes 1–7: 0, 5, 50, 100, 500, 1000,
and 0.
FIG. 5. Substrate deletion analysis. A, band mobility shift analysis
of substrates based on the GluR-B R/G editing site. RNAs in which a
region either proximal or distal to the loop was deleted were compared
with the 78-nucleotide RNA using gel mobility shift analysis. Predicted
secondary structures of the RNAs are shown to the left of the corre-
sponding gel. Mobility shift assays were carried out with ADAR2 con-
centrations increasing from 0 to 180 nM. B, initial editing rates of R/G
site-derived RNAs versus the amount of editing as a function of time.
Editing reactions were carried out under conditions in which half of the
substrate was bound in the ES complex at equilibrium (ADAR2 concen-
tration is equal to Kd1).
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the modulation of activity by heterodimer formation are no
doubt intimately involved in the regulation of the activity of
these enzymes, including the site-specificity of editing.
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